Methods and materials for treatment of rheumatoid arthritis
US4704273A · kind A · utility
19Cited by
0References
16Claims
0Family size
Inventor
Key dates
| Filing date | Feb 27, 1986 |
| Grant date | Nov 3, 1987 |
| Priority date | — |
| Expiry date | Feb 27, 2006 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/81
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods and compositions useful for alleviating the symptoms of rheumatoid arthritis. In preferred embodiments, the compositions are administered in essentially minute "neutralizing" doses. The compositions comprise mixtures of histamine, immunoglobulin G provocative of RF formation or an immunologically active fraction thereof, collagen and either attenuated measles virus or immunologically active fraction thereof. Illustratively significant relief of symptoms of arthritis disease symptoms is achieved through parenteral (e.g., subcutaneous or sublingual) administration of such compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.